Search

everythinglearnresearchcommunity

for

Search:↓

People with Alopecia areata often have lower Vitamin D levels, which might affect the severity of their condition.

Baricitinib shows promise as a new treatment for certain skin conditions like alopecia areata.

Oral cyclosporine is more effective and safer than betamethasone for treating alopecia areata.

Methylprednisolone infusions can help some people with severe alopecia regrow hair.

Alopecia areata patients, especially women with nail issues or atopic diseases, are at higher risk for other autoimmune diseases.

Hair follicle stem cells reduced hair loss and inflammation in mice with a condition similar to human alopecia.

Tofacitinib helps regrow hair in severe alopecia patients, but more research is needed.

Alopecia areata in elderly people is usually mild and responds well to treatment.

COVID-19 may be linked to hair loss or worsening of hair loss in some people.

Some people developed alopecia areata after COVID-19 vaccination, but it's not caused by the vaccine and most improved with treatment.

Alopecia areata patients have higher levels of IL-6 and TNF-α.

Platelet-rich plasma injections can effectively treat alopecia areata barbae.

Triamcinolone acetonide mesotherapy may be effective for treating patchy hair loss in alopecia areata.

People with moderate hair loss from Alopecia Areata feel more impacted than those with no or almost complete hair loss, and are more likely to seek treatment.

Baricitinib helped some patients with tough-to-treat hair loss regrow hair, but more research is needed on its safety.

A woman's hair loss led to discovering she had lupus.

Patients with alopecia areata have higher oxidative stress and lower antioxidant levels.

Microneedling with betamethasone led to almost complete hair regrowth in severe alopecia areata.

Betamethasone is more effective for hair regrowth than latanoprost but has more side effects.

JAK-inhibitors for alopecia areata are generally safe with mostly mild side effects and a low rate of treatment withdrawal.

Early onset, severe types, nail changes, family history, and body hair loss worsen alopecia areata prognosis; sticking to treatment helps.

Microneedles combined with conventional therapies show promise in treating alopecia areata.

Fractional CO2 laser with topical triamcinolone is more effective and safer for treating alopecia areata than intralesional triamcinolone.

Hair loss from Alopecia Areata is caused by both genes and environment, with several treatments available but challenges in cost and relapse remain.

Higher CD70 and CD27 gene expression in alopecia areata lesions predicts disease severity and activity.

Alopecia areata in children is usually mild and effectively treated with strong topical steroids.

Alopecia areata may be linked to heart issues.

Baricitinib helps improve hair growth in severe alopecia, with better results in less severe cases and higher doses working faster.

New treatments for hair loss from alopecia areata may include targeting immune cells, using stem cells, balancing gut bacteria, applying fatty acids, and using JAK inhibitors.

The paper concludes that the new medication baricitinib needs further testing in a more diverse group of patients with alopecia areata.